Shionogi’s IntraBio acquisition brings Aqneursa, a drug approved for treating two rare neurological disorders and the potential to expand to additional indications, both rare and common. It’s Shionogi’s second big rare disease move this year, following the acquisition of global rights to an amyotrophic lateral sclerosis drug from Tanabe Pharma. The post Shionogi Adds to…
The Trump administration is issuing one-time $90 payments to more than 20 million Medicare beneficiaries to help cover Part B premiums, though the payments may do little to offset rising healthcare costs. The post Trump Administration Announces $90 Payments to Help Cover Medicare Part B Premiums appeared first on MedCity News.
Nobody has ever needed convincing on what to fix. What they’ve lacked is a way to act on it themselves, in something close to real time instead of on a vendor’s roadmap. The post The Biggest Healthcare Fix Might Not Come From a Vendor appeared first on MedCity News.
[Sponsored] Fraud, waste, and abuse (FWA) continue to challenge dental plans as overtreatment, miscoding and inappropriate billing practices drive unnecessary costs and weaken payment integrity. For dental payers, the stakes extend beyond financial losses: these issues can also expose members to unnecessary procedures and consume benefits that should be preserved for appropriate care. The post…
While the immune reset field is mainly focused on depleting pathogenic B cells, ai3Bio is applying its novel approach to inflammatory T cells. The startup’s initial disease targets are autoimmune disorders of the liver that have few treatment options if any at all. The post Immunology Startup ai3Bio Aims to Redefine What It Means to…
The Trump administration’s ACA fraud crackdown will remove 760,000 people from Marketplace coverage, drawing criticism from healthcare experts and advocates. The post Trump’s ACA Fraud Crackdown: Experts Urge Going After Bad Actors, Not Patients appeared first on MedCity News.
Rural patients, Medicaid enrollees, and patients from underrepresented racial and ethnic groups are more likely to go undiagnosed, more likely to be misdiagnosed, and more likely to end up in an emergency department rather than an allergist’s office. The post Closing the Diagnostic Gap: Why Access to Allergy Care Isn’t Equal appeared first on MedCity…
At a recent symposium on privacy, experts discussed how AI supports a faster and oftentimes more insightful approach to data security, while identifying which privacy risks healthcare organizations must monitor. The post Healthcare Privacy Leaders Look to AI to Improve Monitoring and Data Breach Investigations appeared first on MedCity News.
Debunked Podcast co-hosts Arundhati Parmar and Samir Batra discussed the merits of the CMS ACCESS Model (Advancing Chronic Care with Effective, Scalable Solutions) and how it can offer a path to advance value-based care goals. The post Debunked Episode 30: ACCESS Tries to Succeed Where VBC Fails, AI, and UnitedHealth Gets the Last Week Tonight…
The Series A round was led by Canvas Ventures, with participation from Blank Space Ventures, StoryHouse Ventures and HMC INQ. The post Parakeet Health Secures $10M for Conversational Agentic Platform appeared first on MedCity News.